Just a fraction below 3,000. It is one that misses out on a new record. We have a lot boeing on. Waiting for new comment from President Trump at this hour. He is hosting a social media summit at the white house. He is also expected to make announcement of some sort on executive action related to maybe the Citizenship Question being added or not added to the census anything on either topics well bring breaking headlines as soon as we get them. Blake burman is there at the white house for us. Gerri willis. Is fully outfitted down on the floor of the New York Stock Exchange on recordsetting day. Hey, gerry. Reporter United Health systems was propelled. Trump agreed to kill a proposal that would overhaul rebates collected by middlemen in the drug business, between the insurance companies, the Drug Companies. He is going to kill that. The drug Company Costs that really helped company like unitedhealthcare that has optum rx is their middleman company. They are on fire as are others in the ca
Verrica Pharmaceuticals Inc (NASDAQ:VRCA) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
The intermediaries in the prescription drug supply chain are stuck between a rock and a hard place, facing congressional scrutiny and pharmaceutical-industry-backed efforts to reform the multibillion-dollar industry. Pharmacy benefit managers (PBMs) have emerged as a bipartisan target in a divided Congress. Members across the aisle have introduced at least a dozen bills so far…
The largest six pharmacy benefit managers are being scrutinized by the Federal Trade Commission, while Congress is debating the Pharmacy Benefit Transparency Act. Meanwhile, states have their own ideas for reining in what they see as excesses of the industry. With all this heat, what is the message from the head of the Pharmaceutical Care Management Association?
Was Livongo a good business? As Burke, now CEO of Quantum Health, touts its strength to investors ahead of a potential IPO, should the Livongo-Teladoc history give them pause?